Global Sleep Aids market will reach $159,756.6 million by 2031, growing by 6.7% annually over 2021-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, the increasing number of healthcare facilities, and the growing usage of portable and wearable sleep apnea devices.
Highlighted with 81 tables and 84 figures, this 170-page report 鈥淕lobal Sleep Aids 麻豆原创 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, REM Sleep Behavior Disorder, Sleepwalking, Others), Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), and Region: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire global Sleep Aids market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global Sleep Aids market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Region.
Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Smart Bedding
鈥� Sleep Lab Services
鈥� Sleep Apnea Devices
o Adaptive Servo-Ventilators (ASVs)
o Positive Airway Pressure (PAP) Devices
o Oral Appliances
o Facial Interfaces
o Other Sleep Apnea Devices
鈥� Medication
o Prescription Drugs
o OTC Drugs
o Herbal Drugs
鈥� Wearable Devices
鈥� Other Product Types
Based on Indication, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Insomnia
鈥� Sleep Apnea
鈥� Narcolepsy
鈥� Restless Leg Syndrome
鈥� REM Sleep Behavior Disorder
鈥� Sleepwalking
鈥� Other Indications
By Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Drug Stores
鈥� E-Commerce
鈥� Hospital Pharmacies
鈥� Retail Pharmacies
Geographically, the following regions together with the listed national/local markets are fully investigated:
鈥� North America (U.S., Canada, and Mexico)
鈥� Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
鈥� APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
鈥� South America (Brazil, Chile, Argentina, Rest of South America)
鈥� MEA (UAE锛孲audi Arabia锛� South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product Type, Indication and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Advanced Brain Monitoring Inc.
Apex Medical Corp.
Apnea Sciences Corporation
BMC Medical Co., Ltd.
Braebon Medical Corp.
Cadwell Industries Inc.
Cleveland Medical Devices Inc.
Compumedics Limited
Drive DeVilbiss Healthcare Inc.
Fisher & Paykel Healthcare Corp. Ltd.
GlaxoSmithKline plc
Itamer Medical Ltd.
Koninklijke Philips N. V.
Merck & Co., Inc.
Natus Medical Inc.
Nihon Kohden Corporation
Pfizer Inc.
ResMed Inc.
Sanofi S. A.
Sleep Number Corporation
SleepMed Inc.
SomnoMed Inc.
Teva Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of 麻豆原创 Research Methodology 12
1.2.2 麻豆原创 Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 麻豆原创 Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 麻豆原创 Overview and Dynamics 19
2.1 麻豆原创 Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the 麻豆原创 22
2.2 Major Growth Drivers 24
2.3 麻豆原创 Restraints and Challenges 29
2.4 Emerging Opportunities and 麻豆原创 Trends 32
2.5 Porter鈥檚 Fiver Forces Analysis 36
3 Segmentation of Global 麻豆原创 by Product Type 40
3.1 麻豆原创 Overview by Product Type 40
3.2 Smart Bedding 42
3.3 Sleep Lab Services 43
3.4 Sleep Apnea Devices 44
3.4.1 Adaptive Servo-Ventilators (ASVs) 46
3.4.2 Positive Airway Pressure (PAP) Devices 47
3.4.3 Oral Appliances 48
3.4.4 Facial Interfaces 49
3.4.5 Other Sleep Apnea Devices 50
3.5 Medication 51
3.5.1 Prescription Drugs 52
3.5.2 OTC Drugs 53
3.5.3 Herbal Drugs 54
3.6 Wearable Devices 55
3.7 Other Product Types 56
4 Segmentation of Global 麻豆原创 by Indication 57
4.1 麻豆原创 Overview by Indication 57
4.2 Insomnia 59
4.3 Sleep Apnea 60
4.4 Narcolepsy 61
4.5 Restless Leg Syndrome 62
4.6 REM Sleep Behavior Disorder 63
4.7 Sleepwalking 64
4.8 Other Indications 65
5 Segmentation of Global 麻豆原创 by Distribution Channel 66
5.1 麻豆原创 Overview by Distribution Channel 66
5.2 Drug Stores 68
5.3 E-Commerce 69
5.4 Hospital Pharmacies 70
5.5 Retail Pharmacies 71
6 Segmentation of Global 麻豆原创 by Region 72
6.1 Geographic 麻豆原创 Overview 2021-2031 72
6.2 North America 麻豆原创 2021-2031 by Country 76
6.2.1 Overview of North America 麻豆原创 76
6.2.2 U.S. 80
6.2.3 Canada 83
6.2.4 Mexico 85
6.3 European 麻豆原创 2021-2031 by Country 87
6.3.1 Overview of European 麻豆原创 87
6.3.2 Germany 91
6.3.3 U.K. 93
6.3.4 France 95
6.3.5 Spain 97
6.3.6 Italy 99
6.3.7 Netherlands 101
6.3.8 Rest of European 麻豆原创 103
6.4 Asia-Pacific 麻豆原创 2021-2031 by Country 105
6.4.1 Overview of Asia-Pacific 麻豆原创 105
6.4.2 Japan 109
6.4.3 China 112
6.4.4 Australia 114
6.4.5 India 116
6.4.6 South Korea 118
6.4.7 Rest of APAC Region 120
6.5 South America 麻豆原创 2021-2031 by Country 122
6.5.1 Argentina 125
6.5.2 Brazil 127
6.5.3 Chile 129
6.5.4 Rest of South America 麻豆原创 131
6.6 MEA 麻豆原创 2021-2031 by Country 132
6.6.1 UAE 135
6.6.2 Saudi Arabia 137
6.6.3 South Africa 139
6.6.4 Other National 麻豆原创s 141
7 Competitive Landscape 142
7.1 Overview of Key Vendors 142
7.2 New Product Launch, Partnership, Investment, and M&A 145
7.3 Company Profiles 146
Advanced Brain Monitoring Inc. 146
Apex Medical Corp. 148
Apnea Sciences Corporation 149
BMC Medical Co., Ltd. 150
Braebon Medical Corp. 151
Cadwell Industries Inc. 152
Cleveland Medical Devices Inc. 153
Compumedics Limited 154
Drive DeVilbiss Healthcare Inc. 155
Fisher & Paykel Healthcare Corp. Ltd. 156
GlaxoSmithKline plc 157
Itamer Medical Ltd. 158
Koninklijke Philips N. V. 159
Merck & Co., Inc. 160
Natus Medical Inc. 161
Nihon Kohden Corporation 162
Pfizer Inc. 163
ResMed Inc. 164
Sanofi S. A. 165
Sleep Number Corporation 166
SleepMed Inc. 167
SomnoMed Inc. 168
Teva Pharmaceutical Industries Ltd. 169
RELATED REPORTS 170
鈥�
Selected Key Players:
Advanced Brain Monitoring Inc.
Apex Medical Corp.
Apnea Sciences Corporation
BMC Medical Co., Ltd.
Braebon Medical Corp.
Cadwell Industries Inc.
Cleveland Medical Devices Inc.
Compumedics Limited
Drive DeVilbiss Healthcare Inc.
Fisher & Paykel Healthcare Corp. Ltd.
GlaxoSmithKline plc
Itamer Medical Ltd.
Koninklijke Philips N. V.
Merck & Co., Inc.
Natus Medical Inc.
Nihon Kohden Corporation
Pfizer Inc.
ResMed Inc.
Sanofi S. A.
Sleep Number Corporation
SleepMed Inc.
SomnoMed Inc.
Teva Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
听
听
*If Applicable.